The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

scientific article published on 01 October 2019

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12471-019-1270-1
P932PMC publication ID6773794
P698PubMed publication ID30997596

P50authorArthur WildeQ88314138
P2093author name stringL Wong
R Evertz
R N W Hauer
F W Asselbergs
J P van Tintelen
M P van den Berg
J F van der Heijden
N M S de Groot
A S J M Te Riele
F H M van Lint
J A Groeneweg
K Zeppenfeld
L P Bosman
M G P J Cox
Netherlands ACM Registry
P A van der Zwaag
P G A Volders
T E Verstraelen
T P Mast
P2860cites workRisk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.Q52776792
Left Ventricular Non-CompactionQ57279226
Arrhythmogenic right ventricular cardiomyopathyQ64043862
Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statementQ26799094
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics supportQ29547407
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.Q33547357
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force CriteriaQ33764619
Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk managementQ33906065
Right ventricular cardiomyopathy and sudden death in young peopleQ34687427
Right ventricular dysplasia: a report of 24 adult casesQ34714742
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathyQ35382044
Noninvasive Multimodality Imaging in ARVD/CQ36585526
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathyQ36868447
Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age.Q39435410
Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.Q40599526
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family MembersQ41144205
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyQ49913558
Predicting Arrhythmic Risk in Arrhythmogenic Right Ventricular Cardiomyopathy: A Systematic Review and Meta-AnalysisQ50166909
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue10
P304page(s)480-486
P577publication date2019-10-01
P1433published inNetherlands Heart JournalQ2146163
P1476titleThe Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
P478volume27

Reverse relations

cites work (P2860)
Q89805299Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants
Q92359899What if there is no prospective, double blind, randomised trial?

Search more.